Rodgers Brothers’s Calumet Specialty Products CLMT Stock Holding History

Rodgers Brothers’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-5,700	Closed	-$207K	–	158
2013 Q2	$207K	Buy	+5,700	New	+$205K	0.12%	132

Other funds holding CLMT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

EAM

Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return

Rodgers Brothers's CLMT Position: Q3 2013 in Review

Rodgers Brothers sold out of Calumet Specialty Products (CLMT) in Q3 2013, closing a stake of 5,700 shares — an estimated $207K sold.

Rodgers Brothers first reported a position in CLMT in Q2 2013 and held it in 1 quarter. The position peaked at $207K in Q2 2013. 114 funds tracked by Wall St. Rank hold CLMT as of Q3 2013.

Rodgers Brothers reported no remaining Calumet Specialty Products position as of Q3 2013 after selling out during the quarter.
Rodgers Brothers sold 5,700 Calumet Specialty Products shares in Q3 2013, an estimated $207K.
Rodgers Brothers first reported a position in Calumet Specialty Products in Q2 2013 and held it in 1 quarter.
Rodgers Brothers's Calumet Specialty Products position peaked at $207K in Q2 2013.
114 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2013.

Based on Rodgers Brothers's 13F filing for Q3 2013, filed 13 Nov 2013.